Oncolys BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 4588?
Owner TypeNumber of SharesOwnership Percentage
Public Companies845,8003.41%
Individual Insiders981,2003.95%
Institutions1,657,7466.68%
General Public21,338,11686%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 31.7%.


Top Shareholders

Top 18 shareholders own 19.68% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
3.59%
Rakuten Investment Management, Inc.
890,600JP¥578.0m0%0.26%
2.93%
Astellas Pharma Inc.
727,200JP¥472.0m0%no data
2.8%
Central Tanshi Co., Ltd., Asset Management Arm
696,200JP¥451.8m0%1.37%
2.22%
SBI Holdings Inc., Asset Management Arm
551,114JP¥357.7m0%0.12%
2.01%
Yasuo Urata
498,900JP¥323.8m0%no data
1.63%
Evolution Capital Management LLC
405,000JP¥262.8m-9.19%1.92%
0.88%
Hitoshi Nakanishi
219,000JP¥142.1m0%no data
0.83%
Japan Securities Finance Co. Ltd., Asset Management Arm
205,400JP¥133.3m0%0.02%
0.52%
Taizo Kawabata
128,700JP¥83.5m0%no data
0.48%
Asahi Intecc Co., Ltd.
118,600JP¥77.0m0%no data
0.46%
Yasunari Kashihara
115,000JP¥74.6m0%no data
0.44%
Simplex Asset Management Co., Ltd.
109,100JP¥70.8m1.39%0.05%
0.4%
au Kabucom Securities Co., Ltd., Asset Management Arm
100,500JP¥65.2m0%0.33%
0.4%
Matsui Securities Co. Ltd., Asset Management Arm
100,000JP¥64.9m0%0.27%
0.073%
Keiji Yoshimura
18,000JP¥11.7m0%no data
0.0048%
Sumitomo Mitsui Financial Group Inc., Asset Management Arm
1,200JP¥778.1k0%no data
0.004%
Shiro Ohki
1,000JP¥649.2k0%no data
0.0024%
Katsufusa Tachiya
600JP¥389.9k0%no data